Company: FVN
Filing Date: 2025-05-02
Form Type: S-4
Source: 0001829126-25-003304
Chunk: 78

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-05-02
Form: S-4
Chunk 78
---
>

Risk Factors Relating to an Investment in New VIWO’s Ordinary Shares

| ● | Certain judgments obtained against us by New VIWO’s shareholders may not be enforceable. |

| ● | New VIWO’s Key Projected Financial Metrics are subject to significant risks, assumptions, estimates and uncertainties, including assumptions regarding future market and changes in regulations. As a result, New VIWO’s projected revenues, market share, expenses and profitability may differ materially from its expectations. |

| ● | If a public market for New VIWO’s ordinary shares does not develop, investors may not be able to re-sell their ordinary shares, rendering their shares illiquid and possibly resulting in a complete loss of their investment. |

| ● | New VIWO may be unable to obtain additional financing to fund its operations or growth. |

| ● | New VIWO may be subject to securities litigation, which is expensive and could divert management attention. |

| ● | If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about New VIWO or its business, its ordinary shares price and trading volume could decline. |

| ● | If New VIWO cannot satisfy, or continue to satisfy, the initial listing requirements and other rules of Nasdaq, New VIWO’s securities may not be listed or may be delisted, which could negatively impact the price of its securities and your ability to sell them. |

| ● | You may face difficulties in protecting your interests, and your ability to protect your rights through U.S. courts may be limited, because New VIWO is incorporated under Cayman Islands law. |

| ● | You may experience difficulties in effecting service of legal process, enforcing foreign judgments or bringing actions in China against New VIWO or its management named in the proxy statement based on foreign laws. |

| ● | Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect New VIWO’s business, investments and results of operations. |

| ● | Future changes to tax laws could adversely affect New VIWO. |

| ● | New VIWO is an emerging growth company within the meaning of the Securities Act, and if New VIWO takes advantage of certain exemptions from disclosure requirements available to emerging growth companies, this could make New VIWO’s securities less attractive to investors and may make it more difficult to compare New VIWO’s performance with other public companies. |

| ● | As a foreign private issuer, we are not subject to certain U.S. securities law disclosure requirements that apply to a